Iktos Expands AI-Driven Drug Discovery Capabilities with Acquisition of Synsight
Iktos, a pioneering leader in AI and Robotics for drug design, has announced its acquisition of Synsight, a renowned French biotech company specializing in AI-driven drug discovery targeting protein-protein (PPI) and RNA-protein (RPI) interactions. This strategic merger bolsters Iktos’ comprehensive AI-based drug discovery platform, integrating Synsight’s advanced technology to enhance biological testing capabilities crucial for…
